BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 17139617)

  • 1. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
    Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A
    Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
    Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
    Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.
    Bastian PJ; Ellinger J; Heukamp LC; Kahl P; Müller SC; von Rücker A
    Eur Urol; 2007 Mar; 51(3):665-74; discussion 674. PubMed ID: 16956712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa.
    Iacopetta B; Grieu F; Phillips M; Ruszkiewicz A; Moore J; Minamoto T; Kawakami K
    Cancer Sci; 2007 Sep; 98(9):1454-60. PubMed ID: 17640302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection.
    Park SY; Yoo EJ; Cho NY; Kim N; Kang GH
    J Pathol; 2009 Dec; 219(4):410-6. PubMed ID: 19639607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M; Gonzalgo ML; Yegnasubramanian S; Lin X; De Marzo AM; Nelson WG
    J Cell Biochem; 2004 Feb; 91(3):540-52. PubMed ID: 14755684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.
    Song JZ; Stirzaker C; Harrison J; Melki JR; Clark SJ
    Oncogene; 2002 Feb; 21(7):1048-61. PubMed ID: 11850822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R; Ferdinand L; Reis IM; Schlesselman JJ
    Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma.
    Enokida H; Shiina H; Urakami S; Terashima M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Igawa M; Dahiya R
    Cancer; 2006 Jan; 106(1):79-86. PubMed ID: 16323173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
    Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
    Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential repetitive DNA methylation in multiple myeloma molecular subgroups.
    Bollati V; Fabris S; Pegoraro V; Ronchetti D; Mosca L; Deliliers GL; Motta V; Bertazzi PA; Baccarelli A; Neri A
    Carcinogenesis; 2009 Aug; 30(8):1330-5. PubMed ID: 19531770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.